Literature DB >> 655698

Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580.

A Weerkamp, U T Heinen-von Borries, G D Vogels.   

Abstract

Incorporation of precursors into macromolecules is immediately arrested upon treatment of Staphylococcus aureus cells with staphylococcin 1580. Except for a degradation of RNA, induced after about 40 min, no degradation of macromolecules is observed, and no trichloroacetic acid-insoluble components are released from the cells. The protein composition and content of membranes are not affected by staphylococcin 1580 treatment. The fatty acid pattern of cells is not significantly altered. Protoplasts do not lyse apparently upon treatment with staphylococcin 1580, but undergo morphological alterations. Thin sections of cells treated with the bacteriocin for 30 min show extensive mesosome-like structures, mostly arranged in honeycomb arrays connected to the plasma membrane, and alterations in the nucleoid area. Freeze-etched preparations taken after that time reveal alterations in the plasma membrane, presumably in relation to the formation of the mesosomal structures. No alterations were observed after bacteriocin treatment for 5 min, although at that time the permeability of the membrane is strongly affected. The implications of the observed changes with the development of irreversible lesions in the cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655698     DOI: 10.1007/BF00400075

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  21 in total

1.  Effect of Bactericidal Substance from Staphylococcus aureus on Group A Streptococci II. Structural Alterations.

Authors:  C C Clawson; A S Dajani
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

2.  Disappearance of specific proteins from the membranes of colicin-treated cells.

Authors:  J E Knepper; J E Lusk
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

3.  Physiological conditions affecting Staphylococcus aureus susceptibility to staphylococcin 1580.

Authors:  A Weerkamp; G D Vogels
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

4.  Close-to-life preservation of Staphylococcus aureus mesosomes for transmission electron microscopy.

Authors:  M Fooke-Achterrath; K G Lickfeld; V M Reusch; U Aebi; U Tschöpe; B Menge
Journal:  J Ultrastruct Res       Date:  1974-11

5.  Mode of action of a Staphylococcus epidermidis bacteriocin.

Authors:  A M Jetten; G D Vogels
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

6.  The effect of lipid phase transitions on the architecture of bacterial membranes.

Authors:  C W Haest; A J Verkleij; J De Gier; R Scheek; P H Ververgaert; L L Van Deenen
Journal:  Biochim Biophys Acta       Date:  1974-07-12

7.  Characterization of the lipids of mesosomal vesicles and plasma membranes from Staphylococcus aureus.

Authors:  P R Beining; E Huff; B Prescott; T S Theodore
Journal:  J Bacteriol       Date:  1975-01       Impact factor: 3.490

8.  Ultrastructural and biochemical alterations effected by viridin B, a bacterocin of alpha-hemolytic streptococci.

Authors:  A S Dajani; D J Law; R O Bollinger; P S Ecklund
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  Effect of substrate on the fatty acid composition of hydrocabon-utilizing microorganisms.

Authors:  K R Dunlap; J J Perry
Journal:  J Bacteriol       Date:  1967-12       Impact factor: 3.490

10.  Structural features of mesosomes (chondrioids) of Bacillu subtilis after freeze-etching.

Authors:  N Nanninga
Journal:  J Cell Biol       Date:  1968-11       Impact factor: 10.539

View more
  1 in total

1.  Chemiosmotic coupling in Methanobacterium thermoautotrophicum: hydrogen-dependent adenosine 5'-triphosphate synthesis by subcellular particles.

Authors:  H J Doddema; C van der Drift; G D Vogels; M Veenhuis
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.